Aurobindo Pharma Company Description

Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology.

It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams.

The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Aurobindo Pharma Limited

Country	India
Founded	1986
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	27,707
CEO	Kambam Reddy

Contact Details

Address: Galaxy, Plot No. 1 Hyderabad, 500032 India
Phone	91 40 6672 5000
Website	aurobindo.com

Stock Details

Ticker Symbol	AUROPHARMA
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE406A01037
SIC Code	2834

Key Executives

Name	Position
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D.	President of Biologics, Chief Executive Officer of Biologics, Vaccines and Peptid and Director
Kambam Nithyananda Reddy	Vice Chairman and MD
Mettu Madan Mohan Reddy	Whole-Time Director
Santhanam Subramanian	Chief Financial Officer
K.P Ravinatha Shetty	President of Operations
Mula Surya Narayana Murthy	Senior Vice President of Accounts
Dr. S. Vijaya Kumar	President of Technical
Dr. Parveen Kumar Luthra	Chief Scientific Officer
Ilapakurty S R . Chandra Rao	Senior Vice President of Admin
Baddigam Adi Reddy	Compliance Officer and Company Secretary